$RHE
Regional Health Properties Inc

2022 Q3 Form 10-Q Financial Statement

#000095017022017694 Filed on August 23, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $11.03M $8.093M $6.439M
YoY Change 64.58% 25.12% 72.86%
Cost Of Revenue $7.476M $4.222M $2.332M
YoY Change 204.65% 87.31%
Gross Profit $3.554M $3.871M $4.107M
YoY Change -16.34% -8.14%
Gross Profit Margin 32.22% 47.83% 63.78%
Selling, General & Admin $4.484M $3.165M $2.879M
YoY Change 62.17% 14.22% -8.28%
% of Gross Profit 126.17% 81.76% 70.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $600.0K $606.0K $638.0K
YoY Change -7.83% -7.06% -2.6%
% of Gross Profit 16.88% 15.65% 15.53%
Operating Expenses $13.00M $8.622M $3.820M
YoY Change 114.04% 44.13% -5.07%
Operating Profit -$1.971M -$529.0K $287.0K
YoY Change -413.85% -208.85%
Interest Expense $564.0K $639.0K -$647.0K
YoY Change -15.7% -4.05% -5.69%
% of Operating Profit -225.44%
Other Income/Expense, Net $1.600M -$796.0K -$353.0K
YoY Change -348.06% -19.51% -1634.78%
Pretax Income -$371.0K -$1.325M -$713.0K
YoY Change 2082.35% 200.45% -25.88%
Income Tax
% Of Pretax Income
Net Earnings -$371.0K -$1.325M -$661.0K
YoY Change 851.28% 163.42% -34.75%
Net Earnings / Revenue -3.36% -16.37% -10.27%
Basic Earnings Per Share -$1.48 -$2.02
Diluted Earnings Per Share -$1.48 -$2.02 -$377.3K
COMMON SHARES
Basic Shares Outstanding 1.769M 1.768M
Diluted Shares Outstanding 1.769M 1.768M

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.373M $2.616M $6.792M
YoY Change -61.93% -53.56% 62.26%
Cash & Equivalents $2.400M $2.600M $6.800M
Short-Term Investments
Other Short-Term Assets $4.275M $4.136M $3.516M
YoY Change 6.61% 4.55% -3.25%
Inventory
Prepaid Expenses
Receivables $6.230M $4.323M $2.145M
Other Receivables $297.0K $319.0K $362.0K
Total Short-Term Assets $13.18M $11.39M $12.82M
YoY Change 4.88% -1.66% 23.65%
LONG-TERM ASSETS
Property, Plant & Equipment $48.51M $49.07M $50.13M
YoY Change -4.43% -4.45% -4.58%
Goodwill $1.585M $1.585M $1.585M
YoY Change 0.0% 0.0% 0.0%
Intangibles $12.38M $12.49M $12.71M
YoY Change -3.42% -3.39% -3.33%
Long-Term Investments
YoY Change
Other Assets $398.0K $398.0K $398.0K
YoY Change -22.57% -22.57% -22.57%
Total Long-Term Assets $82.25M $88.17M $92.88M
YoY Change -12.93% -7.75% -4.89%
TOTAL ASSETS
Total Short-Term Assets $13.18M $11.39M $12.82M
Total Long-Term Assets $82.25M $88.17M $92.88M
Total Assets $95.43M $99.56M $105.7M
YoY Change -10.84% -7.09% -2.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.478M $4.429M $3.749M
YoY Change -11.23% 30.92% 24.63%
Accrued Expenses $6.854M $5.444M $4.987M
YoY Change 64.64% 63.98% 124.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.33M $9.873M $8.736M
YoY Change 27.86% 47.29% 66.94%
LONG-TERM LIABILITIES
Long-Term Debt $52.57M $52.67M $52.88M
YoY Change -1.55% -2.76% -2.87%
Other Long-Term Liabilities $26.63M $30.81M $33.69M
YoY Change -23.2% -13.36% -9.56%
Total Long-Term Liabilities $52.57M $52.67M $52.88M
YoY Change -1.55% -2.76% -2.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.33M $9.873M $8.736M
Total Long-Term Liabilities $52.57M $52.67M $52.88M
Total Liabilities $89.53M $93.35M $95.30M
YoY Change -6.89% -3.19% -1.67%
SHAREHOLDERS EQUITY
Retained Earnings -$119.2M -$118.8M -$114.5M
YoY Change 1.04%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.900M $6.213M $10.40M
YoY Change
Total Liabilities & Shareholders Equity $95.43M $99.56M $105.7M
YoY Change -10.84% -7.09% -2.16%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$371.0K -$1.325M -$661.0K
YoY Change 851.28% 163.42% -34.75%
Depreciation, Depletion And Amortization $600.0K $606.0K $638.0K
YoY Change -7.83% -7.06% -2.6%
Cash From Operating Activities $627.0K -$1.219M $782.0K
YoY Change -63.65% -3394.59% 106.33%
INVESTING ACTIVITIES
Capital Expenditures -$31.00K -$72.00K -$4.000K
YoY Change -31.11% 75.61% -98.34%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$31.00K -$72.00K -$4.000K
YoY Change -31.11% 75.61% -98.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -723.0K -701.0K -556.0K
YoY Change 10.72% 20.03% 41.84%
NET CHANGE
Cash From Operating Activities 627.0K -1.219M 782.0K
Cash From Investing Activities -31.00K -72.00K -4.000K
Cash From Financing Activities -723.0K -701.0K -556.0K
Net Change In Cash -127.0K -1.992M 222.0K
YoY Change -112.37% 238.78% -187.4%
FREE CASH FLOW
Cash From Operating Activities $627.0K -$1.219M $782.0K
Capital Expenditures -$31.00K -$72.00K -$4.000K
Free Cash Flow $658.0K -$1.147M $786.0K
YoY Change -62.82% -1570.51% 26.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1302000
us-gaap Share Based Compensation
ShareBasedCompensation
115000
us-gaap Share Based Compensation
ShareBasedCompensation
123000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001004724
dei Entity Registrant Name
EntityRegistrantName
REGIONAL HEALTH PROPERTIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
GA
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33135
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-5166048
dei Entity Address Address Line1
EntityAddressAddressLine1
454 Satellite Boulevard NW
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Suwanee
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30024
dei City Area Code
CityAreaCode
678
dei Local Phone Number
LocalPhoneNumber
869-5116
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1768720
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49072000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50127000
CY2022Q2 us-gaap Cash
Cash
2616000
CY2021Q4 us-gaap Cash
Cash
6792000
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
2908000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
3056000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
759000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
177000
CY2022Q2 us-gaap Receivables From Customers
ReceivablesFromCustomers
4323000
CY2021Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
2145000
CY2022Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1228000
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
460000
CY2022Q2 us-gaap Notes Receivable Net
NotesReceivableNet
319000
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
362000
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2471000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27151000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29909000
CY2022Q2 us-gaap Goodwill
Goodwill
1585000
CY2021Q4 us-gaap Goodwill
Goodwill
1585000
CY2022Q2 us-gaap Security Deposit
SecurityDeposit
398000
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
398000
CY2022Q2 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
7371000
CY2021Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
8257000
CY2022Q2 us-gaap Assets
Assets
99564000
CY2021Q4 us-gaap Assets
Assets
105696000
CY2022Q2 us-gaap Senior Long Term Notes
SeniorLongTermNotes
45278000
CY2021Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
46043000
CY2022Q2 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
6117000
CY2021Q4 us-gaap Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
6239000
CY2022Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
1275000
CY2021Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
594000
CY2022Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
4429000
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3749000
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
5444000
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
4987000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
29460000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
32059000
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
1348000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1629000
CY2022Q2 us-gaap Liabilities
Liabilities
93351000
CY2021Q4 us-gaap Liabilities
Liabilities
95300000
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1769000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1775000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1760000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1775000
CY2022Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
62584000
CY2021Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
62515000
CY2022Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2021Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
99564000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2812000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2812000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2812000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2812000
CY2022Q2 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
70288000
CY2021Q4 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
70288000
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
62423000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
62423000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118794000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-114542000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6213000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10396000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
105696000
CY2022Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3261000
CY2021Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3763000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
7326000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
7844000
CY2022Q2 us-gaap Revenues
Revenues
8093000
CY2021Q2 us-gaap Revenues
Revenues
6468000
us-gaap Revenues
Revenues
14740000
us-gaap Revenues
Revenues
13549000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
606000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
652000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1219000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1302000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
921000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
952000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2054000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1995000
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
466000
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
37000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2227000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
77000
CY2022Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
629000
CY2021Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
297000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
968000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
536000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
8622000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
5982000
us-gaap Operating Expenses
OperatingExpenses
16625000
us-gaap Operating Expenses
OperatingExpenses
11961000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-529000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
486000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1885000
us-gaap Operating Income Loss
OperatingIncomeLoss
1588000
CY2022Q2 us-gaap Interest Expense
InterestExpense
639000
CY2021Q2 us-gaap Interest Expense
InterestExpense
666000
us-gaap Interest Expense
InterestExpense
1291000
us-gaap Interest Expense
InterestExpense
1353000
CY2022Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
157000
CY2021Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
323000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1076000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
717000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-796000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-989000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2367000
us-gaap Net Income Loss
NetIncomeLoss
-482000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2070000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1325000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-503000
us-gaap Net Income Loss
NetIncomeLoss
-4252000
CY2022Q2 rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
2249000
CY2021Q2 rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
2249000
rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
4498000
rhe Preferred Stock Dividends Undeclared
PreferredStockDividendsUndeclared
4498000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3574000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2752000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8750000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4980000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.02
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.02
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.62
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.93
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.94
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1768000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1768000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1697000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1697000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1775000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1775000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1692000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1692000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10396000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
111000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-46000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2927000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7534000
CY2022Q2 rhe Adjustments To Additional Paid In Capital Forfeitures Of Share Based Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalForfeituresOfShareBasedCompensationRequisiteServicePeriodRecognitionValue
4000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-1325000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6213000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11104000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
21000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11125000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
123000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-7000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-503000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10738000
us-gaap Profit Loss
ProfitLoss
-4252000
us-gaap Profit Loss
ProfitLoss
-482000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1219000
us-gaap Operating Lease Expense
OperatingLeaseExpense
153000
us-gaap Operating Lease Expense
OperatingLeaseExpense
34000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-73000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-1229000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
44000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
55000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2227000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
77000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3446000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-637000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-358000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-244000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1138000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1471000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-281000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
155000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2798000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2387000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
152000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-152000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
806000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
1078000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
572000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
121000
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
50000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1374000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1206000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4324000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1107000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9848000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7492000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5524000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8599000
us-gaap Interest Paid Net
InterestPaidNet
1256000
us-gaap Interest Paid Net
InterestPaidNet
1435000
rhe Vendor Financed Insurance
VendorFinancedInsurance
1078000
rhe Vendor Financed Insurance
VendorFinancedInsurance
867000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2100000
CY2022Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5082000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2322000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
759000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
177000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4323000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2145000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
219000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
606000
rhe Percentage Of Anticipated Monthly Rental Receipts From Tenants
PercentageOfAnticipatedMonthlyRentalReceiptsFromTenants
0.73
CY2021Q4 rhe Minimum Number Of Employees Required Under Employer For Mandatory Vaccinatio
MinimumNumberOfEmployeesRequiredUnderEmployerForMandatoryVaccinatio
100
rhe Relief Fund Authorized Cares Act Ppphce Act And Caa
ReliefFundAuthorizedCaresActPpphceActAndCaa
178000000000
CY2021Q4 rhe Relief Fund Allocation Cares Act
ReliefFundAllocationCARESAct
17000000000
CY2021Q4 rhe Relief Fund Allocation American Rescue Plan
ReliefFundAllocationAmericanRescuePlan
8500000000
rhe Expected Percentage Of Reduction In Medicare Payments Due To Adjustments
ExpectedPercentageOfReductionInMedicarePaymentsDueToAdjustments
0.02
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain reclassifications have been made to the amounts in prior periods in order to conform to the current period’s presentation.</span></p>
CY2022Q2 rhe Penalty For Service Contract Non Performance
PenaltyForServiceContractNonPerformance
50000
rhe Percentage Of Additional Allowance For Patient Care Receivables
PercentageOfAdditionalAllowanceForPatientCareReceivables
0.015
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4300000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1200000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
500000
CY2022Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
4429000
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3749000
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
1300000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1600000
us-gaap Depreciation
Depreciation
1000000
us-gaap Depreciation
Depreciation
1083000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
110000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
219000
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0798
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Accounts Payable
DisposalGroupIncludingDiscontinuedOperationAccountsPayable
2600000
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable
DisposalGroupIncludingDiscontinuedOperationAccountsPayable
2500000
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
700000
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
700000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
52000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
71000
CY2022Q2 rhe Antidilutive Securities Excluded From Computation Of Earnings Per Share Intrinsic Value
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareIntrinsicValue
0
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2600000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2800000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
52700000
CY2022Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1100000
CY2022Q2 rhe Long Term Debt Maturities Repayments Of Principal In Next Twelve Months Subject To Non Default In Payments
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsSubjectToNonDefaultInPayments
2500000
CY2022Q2 rhe Number Of Additional Facilities Licensed
NumberOfAdditionalFacilitiesLicensed
3
CY2022Q2 rhe Number Of Additional Facilities Licensed
NumberOfAdditionalFacilitiesLicensed
3
CY2021Q1 us-gaap Property Management Fee Percent Fee
PropertyManagementFeePercentFee
0.05
CY2021Q2 rhe Variable Rent Recognized
VariableRentRecognized
100000
CY2021 rhe Prior Leases Contracted Cash Rent
PriorLeasesContractedCashRent
3700000
CY2022Q2 us-gaap Cash
Cash
2616000
CY2021Q4 us-gaap Cash
Cash
6792000
CY2022Q2 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
2001000
CY2021Q4 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
1914000
CY2022Q2 rhe Escrow Deposit Current
EscrowDepositCurrent
527000
CY2021Q4 rhe Escrow Deposit Current
EscrowDepositCurrent
700000
CY2022Q2 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2021Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
2908000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
3056000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5524000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9848000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71681000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72965000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22609000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22838000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49072000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50127000
CY2022Q2 us-gaap Land Improvements
LandImprovements
100000
CY2022Q2 us-gaap Depreciation
Depreciation
496000
CY2021Q2 us-gaap Depreciation
Depreciation
543000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
652000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1219000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1302000
CY2021Q4 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16953000
CY2021Q4 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4240000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12713000
CY2021Q4 us-gaap Goodwill
Goodwill
1585000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
219000
CY2022Q2 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16953000
CY2022Q2 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4459000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12494000
CY2022Q2 us-gaap Goodwill
Goodwill
1585000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
110000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
219000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
219000
rhe Operating Leases Number Of Skilled Nursing Facilities Leased
OperatingLeasesNumberOfSkilledNursingFacilitiesLeased
9
rhe Number Of Skilled Nursing Facilities Operated By Third Party Tenants
NumberOfSkilledNursingFacilitiesOperatedByThirdPartyTenants
4
CY2022Q2 rhe Number Of Sublease Agreements Executed Leased By Company
NumberOfSubleaseAgreementsExecutedLeasedByCompany
3
CY2022Q2 rhe Lessee Operating Lease Liability Future Rental Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityFutureRentalPaymentsRemainderOfFiscalYear
3162000
CY2022Q2 rhe Lessee Operating Lease Accretion Of Lease Liability Remainder Of Fiscal Year
LesseeOperatingLeaseAccretionOfLeaseLiabilityRemainderOfFiscalYear
162000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2999000
CY2022Q2 rhe Lessee Operating Lease Liability Future Rental Payments Due Year One
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearOne
6371000
CY2022Q2 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year One
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearOne
647000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5725000
CY2022Q2 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Two
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearTwo
7358000
CY2022Q2 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Two
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearTwo
1227000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6130000
CY2022Q2 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Three
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearThree
7575000
CY2022Q2 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Three
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearThree
1744000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5831000
CY2022Q2 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Four
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearFour
7274000
CY2022Q2 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Four
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearFour
2102000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5173000
CY2022Q2 rhe Lessee Operating Lease Liability Future Rental Payments Due After Year Four
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueAfterYearFour
5502000
CY2022Q2 rhe Lessee Operating Lease Accretion Of Lease Liability Due After Year Four
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueAfterYearFour
1900000
CY2022Q2 rhe Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
3602000
CY2022Q2 rhe Lessee Operating Lease Liability Future Rental Payments
LesseeOperatingLeaseLiabilityFutureRentalPayments
37242000
CY2022Q2 rhe Lessee Operating Lease Accretion Of Lease Liability
LesseeOperatingLeaseAccretionOfLeaseLiability
7782000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
29460000
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0798
rhe Number Of Owned Facilities Lessor
NumberOfOwnedFacilitiesLessor
11
rhe Number Of Owned Facilities
NumberOfOwnedFacilities
12
rhe Number Of Owned Facilities Sub Lessor
NumberOfOwnedFacilitiesSubLessor
8
rhe Number Of Owned Facilities Self Operated
NumberOfOwnedFacilitiesSelfOperated
1
rhe Number Of Owned And Leased Out Facilities Lessor
NumberOfOwnedAndLeasedOutFacilitiesLessor
11
rhe Weighted Average Remaining Lease Term Facilities Lessor
WeightedAverageRemainingLeaseTermFacilitiesLessor
P5Y4M24D
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
4056000
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
9878000
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
9732000
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
9645000
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
9040000
CY2022Q2 rhe Lessor Operating Lease Payments To Be Received After Year Four
LessorOperatingLeasePaymentsToBeReceivedAfterYearFour
17110000
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
59461000
CY2022Q2 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
571000
CY2021Q4 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
343000
CY2022Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1672000
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1391000
CY2022Q2 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
154000
CY2021Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
162000
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
200000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
206000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
192000
CY2022Q2 rhe Medicaid Overpayment Healthcare Services
MedicaidOverpaymentHealthcareServices
1543000
CY2021Q4 rhe Medicaid Overpayment Healthcare Services
MedicaidOverpaymentHealthcareServices
1529000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1304000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1164000
CY2022Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5444000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4987000
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
53927000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
54178000
CY2022Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1135000
CY2021Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1177000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
122000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
125000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
52670000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
52876000
CY2022Q2 rhe Debt Instrument Number Of Credit Related Instruments
DebtInstrumentNumberOfCreditRelatedInstruments
16
CY2022Q2 rhe Long Term Debt Maturities Repayments Of Principal In Reminder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalInReminderOfFiscalYear
2554000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
2404000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
2002000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
2099000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
8774000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
36094000
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
53927000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
122000
CY2022Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1135000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
52670000
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0
CY2021Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0
CY2022Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
13000
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y
CY2022Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
47.53
CY2022Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
13000
CY2022Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
47.53
CY2022Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
10
CY2022Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
10
CY2022Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
10
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Additional Information About Entitys Reportable Segments
AdditionalInformationAboutEntitysReportableSegments
(i) Real Estate Services, which consists of the leasing and subleasing of long-term care and senior living facilities to third-party tenants, including the Company’s management of three facilities on behalf of third-party owners; and (ii) Healthcare Services, which consists of the operation of the LaGrange, Lumber City, Meadowood, and Tara Facilities.
CY2022Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3261000
CY2021Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3763000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
7326000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
7844000
CY2022Q2 us-gaap Revenues
Revenues
8093000
CY2021Q2 us-gaap Revenues
Revenues
6468000
us-gaap Revenues
Revenues
14740000
us-gaap Revenues
Revenues
13549000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
606000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
652000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1219000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1302000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
921000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
952000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2054000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1995000
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
466000
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
37000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2227000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
77000
CY2022Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
629000
CY2021Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
297000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
968000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
536000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
8622000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
5982000
us-gaap Operating Expenses
OperatingExpenses
16625000
us-gaap Operating Expenses
OperatingExpenses
11961000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-529000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
486000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1885000
us-gaap Operating Income Loss
OperatingIncomeLoss
1588000
CY2022Q2 us-gaap Interest Expense
InterestExpense
639000
CY2021Q2 us-gaap Interest Expense
InterestExpense
666000
us-gaap Interest Expense
InterestExpense
1291000
us-gaap Interest Expense
InterestExpense
1353000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
157000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
323000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1076000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
717000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-796000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-989000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2367000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2070000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1325000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-503000
us-gaap Net Income Loss
NetIncomeLoss
-4252000
us-gaap Net Income Loss
NetIncomeLoss
-482000

Files In Submission

Name View Source Status
0000950170-22-017694-index-headers.html Edgar Link pending
0000950170-22-017694-index.html Edgar Link pending
0000950170-22-017694.txt Edgar Link pending
0000950170-22-017694-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rhe-20220630.htm Edgar Link pending
rhe-20220630.xsd Edgar Link pending
rhe-ex31_1.htm Edgar Link pending
rhe-ex31_2.htm Edgar Link pending
rhe-ex32_1.htm Edgar Link pending
rhe-ex32_2.htm Edgar Link pending
Show.js Edgar Link pending
rhe-20220630_def.xml Edgar Link unprocessable
rhe-20220630_lab.xml Edgar Link unprocessable
rhe-20220630_pre.xml Edgar Link unprocessable
rhe-20220630_htm.xml Edgar Link completed
rhe-20220630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable